Hepatitis C Virus: Epidemiology and Clinical Features of Related Cancer

2014 ◽  
pp. 87-112
Author(s):  
Albert Ndzengue ◽  
Tae Hyo Kim ◽  
Abdirashid M. Shire ◽  
Lewis R. Roberts
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Clinical Features

scholarly journals Clinical features of HBe antigen-positive cases of superinfection with hepatitis B virus and hepatitis C virus.

Kanzo ◽  
1994 ◽  
Vol 35 (8) ◽  
pp. 573-579
Author(s):  
Sadamu HOMMA ◽  
Kyoichiro TOSHIMA ◽  
Eisuke INADAMA ◽  
Masayuki KANEKI ◽  
Seika SHIMADA ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Clinical Features ◽  
Hbe Antigen ◽  
B Virus

scholarly journals Screening for anti HCV

2016 ◽  
Vol 10 (2) ◽  
Author(s):  
Fatima Mehboob
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Observational Study ◽  
General Practitioners ◽  
Clinical Features ◽  
Screening Strategy ◽  
Medical Ward ◽  
Hcv Infection ◽  
Hepatitis C Virus Infection

Purpose of this study is to evaluate the different indications for screening for Anti HCV. This study was carried out in outdoor and indoor department of North Medical Ward of Mayo Hospital, Lahore. This is a non-interventional observational study. Two hundred patients ELISA proved HCV infection were evaluated to find out what were the different circumstances or symptomatology when tests for HCV infection were advised. So that a screening strategy can be formed. As hepatitis C virus infection has varied presentation and clinical features, the general practitioners, physicians, dermatologists and psychiatrists should be conscious about it an advise for Anti HCV detection whenever it is suspected. Screening of the early cases is beneficial both for the patients and its relatives.

Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy

2011 ◽  
Vol 46 (6) ◽  
pp. 799-808 ◽  
Author(s):  
Yuko Nagaoki ◽  
Hiroshi Aikata ◽  
Daisuke Miyaki ◽  
Eisuke Murakami ◽  
Yoshimasa Hashimoto ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Clinical Features ◽  
Interferon Therapy ◽  
Virus Eradication

scholarly journals Clinical Features of Hepatitis C Virus Carriers With Persistently normal Alanine Aminotransferase Levels

2012 ◽  
Vol 12 (2) ◽  
pp. 77-84 ◽  
Author(s):  
Hirofumi Uto ◽  
Seiich Mawatari ◽  
Kotaro Kumagai ◽  
Akio Ido ◽  
Hirohito Tsubouchi
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Clinical Features ◽  
Alanine Aminotransferase ◽  
Normal Alanine Aminotransferase

Clinical features and progression of perinatally acquired hepatitis C virus infection

2003 ◽  
Vol 70 (3) ◽  
pp. 373-377 ◽  
Author(s):  
Massimo Resti ◽  
Paloma Jara ◽  
Loreto Hierro ◽  
Chiara Azzari ◽  
Raffaella Giacchino ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Clinical Features ◽  
Hepatitis C Virus Infection ◽  
Perinatally Acquired

The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay

2015 ◽  
Vol 51 (1) ◽  
pp. 63-70 ◽  
Author(s):  
Toshiki Kan ◽  
Senju Hashimoto ◽  
Naoto Kawabe ◽  
Michihito Murao ◽  
Takuji Nakano ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Clinical Features ◽  
Invader Assay

scholarly journals Viraemic frequencies and seroprevalence of non-primate hepacivirus and equine pegiviruses in horses and other mammalian species

2014 ◽  
Vol 95 (8) ◽  
pp. 1701-1711 ◽  
Author(s):  
Sinéad Lyons ◽  
Amit Kapoor ◽  
Bradley S. Schneider ◽  
Nathan D. Wolfe ◽  
Geoff Culshaw ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Liver Disease ◽  
Hepatitis C ◽  
Clinical Features ◽  
Mammalian Species ◽  
Viral Clearance ◽  
Horse Population ◽  
Specific Antibodies ◽  
Past Exposure ◽  
Single Exception

Non-primate hepacivirus (NPHV), equine pegivirus (EPgV) and Theiler’s disease associated virus (TDAV) are newly discovered members of two genera in the Flaviviridae family, Hepacivirus and Pegivirus respectively, that include human hepatitis C virus (HCV) and human pegivirus (HPgV). To investigate their epidemiology, persistence and clinical features of infection, large cohorts of horses and other mammalian species were screened for NPHV, EPgV and TDAV viraemia and for past exposure through serological assays for NPHV and EPgV-specific antibodies. NPHV antibodies were detected in 43 % of 328 horses screened for antibodies to NS3 and core antibodies, of which three were viraemic by PCR. All five horses that were stablemates of a viraemic horse were seropositive, as was a dog on the same farm. With this single exception, all other species were negative for NPHV antibodies and viraemia: donkeys (n = 100), dogs (n = 112), cats (n = 131), non-human primates (n = 164) and humans (n = 362). EPgV antibodies to NS3 were detected in 66.5 % of horses, including 10 of the 12 horses that had EPgV viraemia. All donkey samples were negative for EPgV antibody and RNA. All horse and donkey samples were negative for TDAV RNA. By comparing viraemia frequencies in horses with and without liver disease, no evidence was obtained that supported an association between active NPHV and EPgV infections with hepatopathy. The study demonstrates that NPHV and EPgV infections are widespread and enzootic in the study horse population and confirms that NPHV and potentially EPgV have higher frequencies of viral clearance than HCV and HPgV infections in humans.

Hepatitis C virus genotype 4 infection in the United States; Clinical features and response to therapy

2001 ◽  
Vol 120 (5) ◽  
pp. A381
Author(s):  
Sunil Ramrakhiani ◽  
Bruce R. Bacon ◽  
Sreelatha C. Varma ◽  
Sanjay Ramrakhiani ◽  
Adrian M. Di Bisceglie
Keyword(s):  
United States ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Clinical Features ◽  
The United States ◽  
Response To Therapy ◽  
Virus Genotype ◽  
Genotype 4
Sign in / Sign up

Export Citation Format

Share Document